Intervention
ras peptide cancer vaccine
ClinicalTrials.gov intervention label
Advertisement
Clinical trials
4 shownVaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung CancerNCT00005630 · 1999-07-01
COMPLETEDVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsNCT00019331 · 1997-10-01
COMPLETEDVaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerNCT00019084 · 1996-02-01
COMPLETEDVaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerNCT00019006 · 1995-03-01
COMPLETEDCommon conditions
Lung Cancer3Colorectal Cancer2Pancreatic Cancer2Breast Cancer1Cervical Cancer1Endometrial Cancer1Extensive Stage Small Cell Lung Cancer1Head and Neck Cancer1Limited Stage Small Cell Lung Cancer1Liver Cancer1Melanoma (Skin)1Ovarian Cancer1Recurrent Colon Cancer1Recurrent Pancreatic Cancer1Recurrent Rectal Cancer1Stage I Pancreatic Cancer1Stage II Non-small Cell Lung Cancer1Stage II Pancreatic Cancer1Stage III Colon Cancer1Stage III Non-small Cell Lung Cancer1Stage III Pancreatic Cancer1Stage III Rectal Cancer1Stage IVA Pancreatic Cancer1Stage IVB Pancreatic Cancer1Testicular Germ Cell Tumor1
Leading sponsors
Trial status mix
COMPLETED4
Phase mix
PHASE12
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.